As more disease management programs enlist pharmacists in the management of patients with diabetes, cost-benefit analyses are beginning to show significant savings.
According to a recent study published in the Journal of Managed Care Pharmacy, the VA Medical Center in Pittsburgh found that patients with type 2 diabetes who were enrolled in its pharmacist-based program experienced significant improvements in glycemic control within 6 months.The estimated net savings was more than $103,000 per year for 15 of the most severely ill patients.And in Asheville, NC, a network of community pharmacists saved the city more than $900 per diabetes patient per year. Elsewhere, evaluations of community pharmacists? diabetes-related interventions have put the 1 time cost savings from the prevention of hospitalizations or unnecessary office visits at $4,295 per patient.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs